Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
Journal of Neuro-Oncology|March 7, 2016
Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I studyShamik Chakraborty, Christopher G Filippi, Tamika Wong, et al.Health Physics|February 25, 2017
Radiation Exposure and Safety Precautions Following 131Cs Brachytherapy in Patients with Brain TumorsMenachem Z Yondorf, Theodore H Schwartz, John A Boockvar, et al.Brachytherapy|October 24, 2009
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective studyA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.World Neurosurgery|July 27, 2020
Vascularized Temporoparietal Fascial Flap: A Novel Surgical Technique to Bypass the Blood-Brain Barrier in GlioblastomaNitesh V Patel, Deepak Khatri, Randy D'Amico, et al.Journal of Cancer Research and Therapeutics|May 19, 2010
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resectionA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.Operative Neurosurgery (Hagerstown, Md.)|November 27, 2018
First-in-Man Clinical Experience Using a High-Definition 3-Dimensional Exoscope System for MicroneurosurgeryAlexander A Khalessi, Ralph Rahme, Robert C Rennert, et al.Cancers|January 11, 2024
Reconstruction of the Anterior Skull Base Using the Nasoseptal Flap: A ReviewMichael T Werner, Desmond Yeoh, Judd H Fastenberg, et al.Journal of Experimental Therapeutics & Oncology|May 24, 2018
Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastomaKay O Kulason, Julia R Schneider, Shamik Chakraborty, et al.Journal of Neurosurgery|July 15, 2017
Do craniopharyngioma molecular signatures correlate with clinical characteristics?Sacit Bulent Omay, Yu-Ning Chen, Joao Paulo Almeida, et al.Journal of Neuro-Oncology|October 3, 2021
Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trialNitesh V Patel, Tamika Wong, Sherese R Fralin, et al.Pageof 11